‘Innovative vaccines on a massive scale’: Sanofi to create $475m vaccine production site in Singapore

Sanofi will build a digitally-enabled, carbon-neutral vaccine manufacturing center in Singapore: designed to respond quickly to future pandemic risks and able to produce up to four vaccines simultaneously.